Medical network - April 21, yesterday (20), the ministry announced 2016 completion pharmaceutical industry the main economic indicators. 

 

▍ pharmaceutical industry scored first in the country 

 

The most beautiful transcripts pharmaceutical industry the national industrial once again. 

 

In 2016, according to data of large pharmaceutical industrial added value growth of 10.6% year-on-year, growth is increased by 0.8% year-on-year, the overall growth rate of 4.6%, higher than the national industry in the industry the industry forefront. Added value of pharmaceutical industry in the whole industrial added value accounted for 3.3%, year-on-year growth of 0.3%, pharmaceutical industry's contribution to the growth of industrial economy to further expand. 

 

Advocate business wu income, 2016 medical industrial enterprises above designated size implementation main business income is 2.963586 trillion yuan, up 9.92% from a year earlier, the growth increased by 0.90%, year-on-year growth of 5.02% higher than the national overall industrial growth. 

 

, its one of the fastest growth is medical instruments and equipment manufacturing, chemical pharmaceuticals, proprietary Chinese medicine, pharmaceutical equipment, growth is lower than the industry average. 

 

 

 

▍ 38 drug firms earn to turn over 

 

Most statistic value of profit, the medicine industrial enterprises above designated size in 2016 total profit of 321.643 billion yuan, up 15.57% year on year, growth is increased by 3.35% year-on-year, the overall growth of 7.07% higher than the national industry. Each child in the industry, the fastest growth is chemical pharmaceuticals, pharmaceutical equipment appear negative growth. Pharmaceutical industry above designated size in 2016 main profit margin of 10.85%, improved on the previous year, 4.88% higher than the national industry overall level. 

 

 

 

The statistics from the profits of listed companies also. 

 

According to reports, as of April 19, in 214 a-share listed companies in medicine, there have been 187 disclose earnings forecast in 2016. Of these, 114 is expected to net profit year-on-year growth, including 38 net profit forecast increased more than 100%; 51 downturn, many companies decline is larger; 22 uncertainty - means that the decline in nearly two years growth of the pharmaceutical industry has gradually through the "winter". 

 

China securities news reported, according to statistics according to fiscal transfer big data terminals, the 187 companies operating income growth of about 7.5% on average, year-on-year net profit year-on-year growth of 9.5% on average. 

 

Of the 187 companies, the companies net profit forecast to add 114, accounted for about sixty percent. Among them, 38 companies are expected to net profit rose more than 100%, including the appropriate wide reputation far, national agricultural science and technology, China wide health, pharmaceutical, tai chi group, etc. 

 

Results the main reason for the increase, most enterprises is sales scale and new product listing, denotative expansion and table after profits growth. The company's net profit scale basic in 40 million yuan of above. Wide reputation far net profit of 98 million yuan, is expected to increase to 47 times. 

 

30 companies net profit increase range between 30% and 100%, including the pharmaceutical, CDH innovation, essence pharmaceutical, hundred million sails medicines, etc. The growth of these companies mainly is to acquire assets and tables, or sales scale rise in net profit. And nine medical and pharmaceutical belong to northeast Ann turnround type. 

 

Net profit is expected to decline, in addition, 51 companies accounted for about thirty percent, including jia should pharmaceutical, hokuriku pharmaceutical, DE man, source in the Concorde, bo dhi medicine, the sea is pharmaceutical, double into the pharmaceutical industry, etc. Among them, the sea is pharmaceuticals, double into pharmaceuticals dropped more than 500%. 

 

Miit data also showed that 2016 pharmaceutical industrial enterprises above designated size to achieve the export value of 194.88 billion yuan, up 7.26% from a year earlier, the growth rate increased by 3.66% year-on-year. According to customs import and export data, pharmaceutical products exports to $2016 in 55.414 billion, down 1.82% year on year, the growth rate fell 4.52% from a year. 

 

And began to return to investment in fixed assets is also active in the industry. 

 

Pharmaceutical manufacturing 2016 of investment in fixed assets of 629.9 billion yuan, up 8.4% from a year earlier, the growth rate fell 3.5% from a year, higher than the national overall industrial growth is 4.8%.